These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Candida albicans Biofilms and Human Disease. Nobile CJ; Johnson AD Annu Rev Microbiol; 2015; 69():71-92. PubMed ID: 26488273 [TBL] [Abstract][Full Text] [Related]
3. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans. Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598 [TBL] [Abstract][Full Text] [Related]
4. Biofilm of Candida albicans: formation, regulation and resistance. Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Candida albicans biofilm. Tsui C; Kong EF; Jabra-Rizk MA Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943 [TBL] [Abstract][Full Text] [Related]
6. Development and regulation of single- and multi-species Candida albicans biofilms. Lohse MB; Gulati M; Johnson AD; Nobile CJ Nat Rev Microbiol; 2018 Jan; 16(1):19-31. PubMed ID: 29062072 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Culturing and Screening of Candida albicans Biofilms. Gulati M; Lohse MB; Ennis CL; Gonzalez RE; Perry AM; Bapat P; Arevalo AV; Rodriguez DL; Nobile CJ Curr Protoc Microbiol; 2018 Aug; 50(1):e60. PubMed ID: 29995344 [TBL] [Abstract][Full Text] [Related]
8. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL mBio; 2017 Dec; 8(6):. PubMed ID: 29208749 [No Abstract] [Full Text] [Related]
9. Antifungal susceptibility of Candida albicans in biofilms. Tobudic S; Kratzer C; Lassnigg A; Presterl E Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943 [TBL] [Abstract][Full Text] [Related]
10. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Biofilm Formation by Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910 [No Abstract] [Full Text] [Related]
12. Global Identification of Biofilm-Specific Proteolysis in Candida albicans. Winter MB; Salcedo EC; Lohse MB; Hartooni N; Gulati M; Sanchez H; Takagi J; Hube B; Andes DR; Johnson AD; Craik CS; Nobile CJ mBio; 2016 Sep; 7(5):. PubMed ID: 27624133 [TBL] [Abstract][Full Text] [Related]
13. Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis. Yano J; Yu A; Fidel PL; Noverr MC PLoS One; 2016; 11(7):e0159692. PubMed ID: 27453977 [TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model. El-Azizi M; Farag N; Khardori N Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806 [TBL] [Abstract][Full Text] [Related]
15. Importance of Candida-bacterial polymicrobial biofilms in disease. Harriott MM; Noverr MC Trends Microbiol; 2011 Nov; 19(11):557-63. PubMed ID: 21855346 [TBL] [Abstract][Full Text] [Related]
16. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]